Comparing Adolescent- and Adult-Onset Unexplained Cardiac Arrest - Results from the Dutch Idiopathic VF registry.

adolescent adult electrophysiology idiopathic ventricular fibrillation sudden cardiac arrest ventricular arrhythmias

Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 12 12 2023
revised: 22 02 2024
accepted: 11 03 2024
medline: 18 3 2024
pubmed: 18 3 2024
entrez: 17 3 2024
Statut: aheadofprint

Résumé

Current cohorts of idiopathic ventricular fibrillation (IVF) patients primarily include adult-onset patients. Underlying causes of a sudden cardiac arrest vary with age, therefore underlying causes and disease course may differ for adolescent-onset versus adult-onset patients. To compare adolescent-onset with adult-onset patients with an initially unexplained cause for VF. This study includes 39 patients with an index event ≤19 years (adolescent-onset) and 417 adult-onset patients from the Dutch Idiopathic VF registry. Event circumstances, clinical characteristics, a change in diagnosis, and arrhythmia recurrences were collected and compared between the two groups. In total, 42 patients received an underlying diagnosis during follow-up (median of 7 [2 - 12] years), with a similar yield (15% for adolescent-onset vs. 9% for adult-onset, p=0.16). Among the remaining unexplained patients, adolescent-onset patients (n=33) had their index event at a median age of 17 [16 - 18] years, 72% were male. The youngest patient was 13 years. In comparison with adults (n=381), adolescent-onset patients more often had their index event during exercise (p<0.01). Adolescent-onset patients experienced more appropriate implantable cardioverter defibrillator (ICD) therapy (44% vs. 26%, p=0.03) during follow-up compared with adults. Inappropriate ICD therapy (26% vs. 17%, p=0.19), ICD complications (19% vs. 14%, p=0.41) and deaths (3% vs. 4%, p=1.00) did not significantly differ between adolescent-onset and adult-onset patients. IVF may occur in adolescence. Adolescent-onset patients more often present during exercise compared with adults. Furthermore, they are more vulnerable for ventricular arrhythmias reflected by a higher incidence of appropriate ICD therapy.

Sections du résumé

BACKGROUND BACKGROUND
Current cohorts of idiopathic ventricular fibrillation (IVF) patients primarily include adult-onset patients. Underlying causes of a sudden cardiac arrest vary with age, therefore underlying causes and disease course may differ for adolescent-onset versus adult-onset patients.
OBJECTIVE OBJECTIVE
To compare adolescent-onset with adult-onset patients with an initially unexplained cause for VF.
METHODS METHODS
This study includes 39 patients with an index event ≤19 years (adolescent-onset) and 417 adult-onset patients from the Dutch Idiopathic VF registry. Event circumstances, clinical characteristics, a change in diagnosis, and arrhythmia recurrences were collected and compared between the two groups.
RESULTS RESULTS
In total, 42 patients received an underlying diagnosis during follow-up (median of 7 [2 - 12] years), with a similar yield (15% for adolescent-onset vs. 9% for adult-onset, p=0.16). Among the remaining unexplained patients, adolescent-onset patients (n=33) had their index event at a median age of 17 [16 - 18] years, 72% were male. The youngest patient was 13 years. In comparison with adults (n=381), adolescent-onset patients more often had their index event during exercise (p<0.01). Adolescent-onset patients experienced more appropriate implantable cardioverter defibrillator (ICD) therapy (44% vs. 26%, p=0.03) during follow-up compared with adults. Inappropriate ICD therapy (26% vs. 17%, p=0.19), ICD complications (19% vs. 14%, p=0.41) and deaths (3% vs. 4%, p=1.00) did not significantly differ between adolescent-onset and adult-onset patients.
CONCLUSION CONCLUSIONS
IVF may occur in adolescence. Adolescent-onset patients more often present during exercise compared with adults. Furthermore, they are more vulnerable for ventricular arrhythmias reflected by a higher incidence of appropriate ICD therapy.

Identifiants

pubmed: 38493994
pii: S1547-5271(24)00276-5
doi: 10.1016/j.hrthm.2024.03.031
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Lisa M Verheul (LM)

University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. Electronic address: l.m.verheul-5@umcutrecht.nl.

Wiert F Hoeksema (WF)

Amsterdam UMC location University of Amsterdam, Department of Cardiology, Heart Failure and Arrhythmias, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, the Netherlands.

Sanne A Groeneveld (SA)

University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

Bart A Mulder (BA)

University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

Marianne Bootsma (M)

Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.

Marco Alings (M)

Amphia Hospital, Molengracht 21, 4818 CK, Breda, The Netherlands.

Reinder Evertz (R)

Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.

Andreas C Blank (AC)

Wilhelmina Children's Hospital, Lundlaan 6, 3584 EA, Utrecht, The Netherlands.

Janneke A E Kammeraad (JAE)

Erasmus MC - Sophia Children's hospital, Cardiovascular Institute, Department of pediatric cardiology, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.

Sally-Ann B Clur (SB)

Amsterdam UMC location University of Amsterdam, Department of Cardiology, Heart Failure and Arrhythmias, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, the Netherlands.

Sing-Chien Yap (SC)

Erasmus MC, Cardiovascular Institute, Thorax Center, Erasmus MC, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.

Pieter G Postema (PG)

Amsterdam UMC location University of Amsterdam, Department of Cardiology, Heart Failure and Arrhythmias, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, the Netherlands.

Arthur A M Wilde (AAM)

Amsterdam UMC location University of Amsterdam, Department of Cardiology, Heart Failure and Arrhythmias, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, the Netherlands.

Paul G A Volders (PGA)

Maastricht University Medical Center+, Peter Debyelaan 25, 6229 HX, Maastricht, The Netherlands.

Rutger J Hassink (RJ)

University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

Classifications MeSH